CLINICAL EFFICACY, GLYCEMIC OUTCOMES, AND PATIENT ACCEPTABILITY OF CONTINUOUS GLUCOSE MONITORING SYSTEMS IN PEDIATRIC TYPE 1 DIABETES: A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.31435/ijitss.4(52).2026.6744Keywords:
Continuous Glucose Monitoring (CGM), Type 1 Diabetes, Pediatric Patients, Glycemic ControlAbstract
Background: Background: Continuous glucose monitoring (CGM) has fundamentally transformed the management of type 1 diabetes (T1D) in pediatric populations by providing frequent interstitial glucose measurements and temporal trends. However, clinical efficacy and patient acceptability remain heterogeneous across studies regarding age, technology generation, and treatment regimens.
Aim: This systematic review aimed to evaluate the clinical efficacy, glycemic outcomes, and patient acceptability of CGM systems in pediatric patients with T1D, focusing on changes in HbA1c, CGM-derived metrics, hypoglycemia reduction, and quality of life.
Methods: Conducted in accordance with PRISMA guidelines, a systematic literature search across multiple databases identified prospective interventional and observational studies evaluating CGM use in children and adolescents aged <18 years diagnosed with T1D. Twenty-nine studies meeting the inclusion criteria were analyzed.
Results: CGM use demonstrated meaningful improvements in glycemic metrics, particularly increasing Time in Range (TIR), reducing Time Below Range (TBR) and Time Above Range (TAR), decreasing glycemic variability, and enhancing the detection of asymptomatic and nocturnal hypoglycemia. While HbA1c reductions varied—being most pronounced in participants with higher baseline values—the greatest metabolic and glycemic benefits were consistently observed with regular, sustained sensor use and when CGM was integrated into automated insulin delivery (AID) systems. Patient and caregiver satisfaction was generally high, though practical challenges such as local skin reactions, adhesive failures, sensor discomfort, and alarm burden were documented.
Conclusions: CGM is a valuable component of pediatric T1D management, providing essential glycemic insights beyond HbA1c alone. Its clinical effectiveness relies heavily on consistent sensor adherence, appropriate education, family engagement, and the integration of technology into daily therapeutic decisions.
References
de Bock, M., Agwu, J. C., Deabreu, M., Dovc, K., Maahs, D. M., Marcovecchio, M. L., Mahmud, F. H., Nóvoa-Medina, Y., Priyambada, L., Smart, C. E., & DiMeglio, L. A. (2024). International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: Glycemic targets. Hormone research in paediatrics, 97(6), 546–554. https://doi.org/10.1159/00054326
Tauschmann, M., Cardona-Hernandez, R., DeSalvo, D. J., Hood, K., Laptev, D. N., Lindholm Olinder, A., Wheeler, B. J., & Smart, C. E. (2024). International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024 diabetes technologies: Glucose monitoring. Hormone research in paediatrics, 97(6), 615–635. https://doi.org/10.1159/000543156
American Diabetes Association Professional Practice Committee (2024). 14. Children and Adolescents: Standards of Care in Diabetes-2024. Diabetes care, 47(Suppl 1), S258–S281. https://doi.org/10.2337/dc24-S014
Guilmin-Crépon, S., Carel, J. C., Schroedt, J., Sulmont, V., Salmon, A. S., Le Tallec, C., Coutant, R., Dalla-Vale, F., Stuckens, C., Bony-Trifunovic, H., Crosnier, H., Kurtz, F., Kaguelidou, F., Le Jeannic, A., Durand-Zaleski, I., Couque, N., Alberti, C., & Tubiana-Rufi, N. (2019). Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month french multi-center, prospective, controlled randomized trial (start-in!). Pediatric diabetes, 20(3), 304–313. https://doi.org/10.1111/pedi.12820
Tansey, M., Weinzimer, S., Beck, R., Ruedy, K., Cheng, P., Tamborlane, W., Kollman, C., Mauras, N., Fox, L., Coffey, J., White, N. H., & Diabetes Research in Children Network (DirecNet) Study Group (2013). Extended 6-month follow-up of a randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes care, 36(5), e63. https://doi.org/10.2337/dc12-2021
Franceschi, R., Micheli, F., Mozzillo, E., Cauvin, V., Liguori, A., Soffiati, M., & Giani, E. (2021). Intermittently scanned and continuous glucose monitor systems: A systematic review on psychological outcomes in pediatric patients. Frontiers in pediatrics, 9, 660173. https://doi.org/10.3389/fped.2021.660173
Rusak, E., Ogarek, N., Wolicka, K., Mrówka, A., Seget, S., Kuźnik, M., & Jarosz-Chobot, P. (2021). The quality of life and satisfaction with continuous glucose monitoring therapy in children under 7 years of age with T1D using the rtcgm system integrated with insulin pump-a caregivers point of view. Sensors (Basel, Switzerland), 21(11), 3683. https://doi.org/10.3390/s21113683
Laffel, L. M., Kanapka, L. G., Beck, R. W., Bergamo, K., Clements, M. A., Criego, A., DeSalvo, D. J., Goland, R., Hood, K., Liljenquist, D., Messer, L. H., Monzavi, R., Mouse, T. J., Prahalad, P., Sherr, J., Simmons, J. H., Wadwa, R. P., Weinstock, R. S., Willi, S. M., Miller, K. M., … CDE10 (2020). Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: A randomized clinical trial. JAMA, 323(23), 2388–2396. https://doi.org/10.1001/jama.2020.6940
Nwosu, B. U., Yeasmin, S., Ayyoub, S., Rupendu, S., Villalobos-Ortiz, T. R., Jasmin, G., Parajuli, S., Zahedi, B., Zitek-Morrison, E., Alonso, L. C., & Barton, B. A. (2020). Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes. Journal of pediatric endocrinology & metabolism : JPEM, 33(7), 865–872. https://doi.org/10.1515/jpem-2020-0057
Messer, L. H., Bauza, C., Miller, K. M., Clements, M. A., DeSalvo, D. J., Sherr, J., Weinstock, R. S., Hood, K., & Laffel, L. M. (2023). Adolescent- and young adult-reported outcomes and use of continuous glucose monitoring features: A report from the city trial. Pediatric diabetes, 2023, 6906023. https://doi.org/10.1155/2023/6906023
Sheikh, K., Bartz, S. K., Lyons, S. K., & DeSalvo, D. J. (2018). Diabetes device use and glycemic control among youth with type 1 diabetes: A single-center, cross-sectional study. Journal of diabetes research, 2018, 5162162. https://doi.org/10.1155/2018/5162162
Raviteja, K. V., Kumar, R., Dayal, D., & Sachdeva, N. (2019). Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: An open-label randomized control trial. Scientific reports, 9(1), 6120. https://doi.org/10.1038/s41598-019-42555-6
Van Name, M. A., Kanapka, L. G., DiMeglio, L. A., Miller, K. M., Albanese-O'Neill, A., Commissariat, P., Corathers, S. D., Harrington, K. R., Hilliard, M. E., Anderson, B. J., Kelley, J. C., Laffel, L. M., MacLeish, S. A., Nathan, B. M., Tamborlane, W. V., Wadwa, R. P., Willi, S. M., Williams, K. M., Wintergerst, K. A., Woerner, S., … DeSalvo, D. J. (2023). Long-term continuous glucose monitor use in very young children with type 1 diabetes: One-year results from the sence study. Journal of diabetes science and technology, 17(4), 976–987. https://doi.org/10.1177/19322968221084667
Miller, K. M., Bauza, C., Kanapka, L. G., Clements, M. A., DeSalvo, D. J., Hood, K., Messer, L. H., Sherr, J., Bergamo, K., Criego, A., Freiner, E., Lyons, S. K., Monzavi, R., Moore, W., Prahalad, P., Simmons, J. H., Sulik, M., Wadwa, R. P., Weinstock, R. S., Willi, S. M., … CITY Study Group (2023). Continuous glucose monitoring provides durable glycemic benefit in adolescents and young adults with type 1 diabetes: 12-month follow-up results. Pediatric diabetes, 2023, 6718115. https://doi.org/10.1155/2023/6718115
Abdelmaksoud, A. A., Al Hayek, A., Matter, R., Salah, N., Shahin, H. H., Reyad, A. R., & Tantawy, N. M. (2025). Continuous glucose monitoring with linx™ improves glycemic control and satisfaction in youth with type 1 diabetes: A real-world observational study. Cureus, 17(9), e91864. https://doi.org/10.7759/cureus.91864
Hobbs, A., Thus, M., Couper, J., Tham, E., & Fairchild, J. (2022). Does introduction of continuous glucose monitoring at diagnosis of type 1 diabetes increase uptake in children and adolescents?. Pediatric diabetes, 23(1), 98–103. https://doi.org/10.1111/pedi.13293
Urakami, T., Yoshida, K., Kuwabara, R., Mine, Y., Aoki, M., Suzuki, J., & Morioka, I. (2020). Significance of "time below range" as a glycemic marker derived from continuous glucose monitoring in japanese children and adolescents with type 1 diabetes. Hormone research in paediatrics, 93(4), 251–257. https://doi.org/10.1159/000510454
De Ridder, F., Charleer, S., Jacobs, S., Bolsens, N., Ledeganck, K. J., Van Aken, S., Vanbesien, J., Gies, I., Casteels, K., Massa, G., Lysy, P. A., Logghe, K., Lebrethon, M. C., Depoorter, S., Gillard, P., De Block, C., & den Brinker, M. (2022). Effect of nationwide reimbursement of real-time continuous glucose monitoring on HbA1c, hypoglycemia and quality of life in a pediatric type 1 diabetes population: The rescue-pediatrics study. Frontiers in pediatrics, 10, 991633. https://doi.org/10.3389/fped.2022.991633
Giani, E., Snelgrove, R., Volkening, L. K., & Laffel, L. M. (2017). Continuous glucose monitoring (CGM) adherence in youth with type 1 diabetes: Associations with biomedical and psychosocial variables. Journal of diabetes science and technology, 11(3), 476–483. https://doi.org/10.1177/1932296816676280
Bukara-Radujkovic, G., & Miljkovic, V. (2024). Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin a1c in pediatric patients on sensor-augmented pump therapy. Frontiers in endocrinology, 15, 1388245. https://doi.org/10.3389/fendo.2024.1388245
Deshpande, S., Weinzimer, S. A., Gibbons, K., Nally, L. M., Weyman, K., Carria, L., Zgorski, M., Laffel, L. M., Doyle, F. J., 3rd, & Dassau, E. (2024). Feasibility and preliminary safety of smartphone-based automated insulin delivery in adolescents and children with type 1 diabetes. Journal of diabetes science and technology, 18(2), 363–371. https://doi.org/10.1177/19322968221116384
Pott, T., Jimenez-Vega, J., Parker, J., & Fitzgerald, R. (2024). Continuous glucose monitoring in pediatric diabetic ketoacidosis. Journal of diabetes science and technology, 18(4), 899–903. https://doi.org/10.1177/19322968221140430
Abraham, M. B., de Bock, M., Smith, G. J., Dart, J., Fairchild, J. M., King, B. R., Ambler, G. R., Cameron, F. J., McAuley, S. A., Keech, A. C., Jenkins, A., Davis, E. A., O'Neal, D. N., Jones, T. W., & Australian Juvenile Diabetes Research Fund Closed-Loop Research group (2021). Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: A randomized clinical trial. JAMA pediatrics, 175(12), 1227–1235. https://doi.org/10.1001/jamapediatrics.2021.3965
Faulds, E. R., Hoffman, R. P., Grey, M., Tan, A., Tubbs-Cooley, H., Militello, L. K., & Happ, M. B. (2020). Self-management among pre-teen and adolescent diabetes device users. Pediatric diabetes, 21(8), 1525–1536. https://doi.org/10.1111/pedi.13131
Lawson, M. L., Verbeeten, K. C., Courtney, J. M., Bradley, B. J., McAssey, K., Clarson, C., Kirsch, S., Curtis, J. R., Mahmud, F. H., Richardson, C., Cooper, T., Chan, J., & Tang, K. (2021). Timing of CGM initiation in pediatric diabetes: The CGM time trial. Pediatric diabetes, 22(2), 279–287. https://doi.org/10.1111/pedi.13144
Diabetes Research in Children Network (DirecNet) Study Group, Buckingham, B., Beck, R. W., Tamborlane, W. V., Xing, D., Kollman, C., Fiallo-Scharer, R., Mauras, N., Ruedy, K. J., Tansey, M., Weinzimer, S. A., & Wysocki, T. (2007). Continuous glucose monitoring in children with type 1 diabetes. The Journal of pediatrics, 151(4), 388–393.e3932. https://doi.org/10.1016/j.jpeds.2007.03.047
McGill, D. E., Volkening, L. K., Butler, D. A., Harrington, K. R., Katz, M. L., & Laffel, L. M. (2018). Baseline psychosocial characteristics predict frequency of continuous glucose monitoring in youth with type 1 diabetes. Diabetes technology & therapeutics, 20(6), 434–439. https://doi.org/10.1089/dia.2018.0037
Edongue Hika, M., Nkoum, M. N., Mbono, R., Mendomo, A., Baron, S., & Sap Ngo Um, S. (2026). Continuous glucose monitoring (CGM): Assessment and impact on glycemic control in children and adolescents with type 1 diabetes in cameroon: A pilot study. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 33(4), 105517. https://doi.org/10.1016/j.arcped.2026.105517
Kadiyala, N., Lakshman, R., Allen, J., Ware, J., Boughton, C. K., Wilinska, M. E., Thankamony, A., Hartnell, S., Thabit, H., Willemsen, R. H., Shah, P., & Hovorka, R. (2025). Fully closed-loop improves glycemic control compared with pump with CGM in adolescents with type 1 diabetes and HbA1c above target: A two-center, randomized crossover study. Diabetes technology & therapeutics, 27(9), 719–727. https://doi.org/10.1089/dia.2025.0062
Verbeeten, K. C., Chan, J., Sourial, N., Courtney, J. M., Bradley, B. J., McAssey, K., Clarson, C., Kirsch, S., Curtis, J. R., Mahmud, F. H., Cooper, T., Richardson, C., Lawson, M. L., CGM TIME Trial Study Group, & JDRF Canadian Clinical Trials Group (2021). Motivational stage at continuous glucose monitoring (CGM) initiation in pediatric type 1 diabetes is associated with current glycemic control but does not predict future CGM adherence or glycemic control. Canadian journal of diabetes, 45(5), 466–472.e4. https://doi.org/10.1016/j.jcjd.2021.04.004
Raviteja, K. V., Kumar, R., Dayal, D., & Sachdeva, N. (2019). Clinical efficacy of professional continuous glucose monitoring in improving glycemic control among children with type 1 diabetes mellitus: An open-label randomized control trial. Scientific reports, 9(1), 6120. https://doi.org/10.1038/s41598-019-42555-6
Zung, A., & Zadik, Z. (2002). Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics, 109(2), 347. https://doi.org/10.1542/peds.109.2.347-a
Yen, K., Belapurkar, S., Puckett, C., Chen, N. S., Yglecias, L., Bal, K. S., Hickey, J. G., Carelli, L. L., Loucel, C. M., Lodish, M., & Wong, J. C. (2025). Pilot study of early adoption of automated insulin delivery in underresourced youth. Journal of diabetes research, 2025, 6886806. https://doi.org/10.1155/jdr/6886806
Wadwa, R. P., Fiallo-Scharer, R., Vanderwel, B., Messer, L. H., Cobry, E., & Chase, H. P. (2009). Continuous glucose monitoring in youth with type 1 diabetes. Diabetes technology & therapeutics, 11 Suppl 1, S83–S91. https://doi.org/10.1089/dia.2008.0122
Tsalikian, E., Fox, L., Weinzimer, S., Buckingham, B., White, N. H., Beck, R., Kollman, C., Xing, D., Ruedy, K., & Diabetes Research in Children Network Study Group (2012). Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatric diabetes, 13(4), 301–307. https://doi.org/10.1111/j.1399-5448.2011.00837.x
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane, W. V., Beck, R. W., Bode, B. W., Buckingham, B., Chase, H. P., Clemons, R., Fiallo-Scharer, R., Fox, L. A., Gilliam, L. K., Hirsch, I. B., Huang, E. S., Kollman, C., Kowalski, A. J., Laffel, L., Lawrence, J. M., Lee, J., Mauras, N., O'Grady, M., Ruedy, K. J., … Xing, D. (2008). Continuous glucose monitoring and intensive treatment of type 1 diabetes. The New England journal of medicine, 359(14), 1464–1476. https://doi.org/10.1056/NEJMoa0805017
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Wiktoria Żelazna , Monika Leśniak , Kalina Światlak, Justyna Trzaskalik

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

